Abstract:Abstract Background Group 3 innate lymphoid cells (ILC3s) have recently emerged as important regulators and potential drug targets for IBD. However, the response of ILC3s to environmental stimuli during intestinal inflammation remains elusive. IRE1a-XBP1 serves as the regulatory hub of endoplasmic reticulum stress and the unfolded protein response (UPR) that plays a vital role in intestinal inflammation. Methods We generated conditional knockout Ire1aflo/flox,Rorc-Cre (Ire1aΔRorc) and Rag-/-Ire1aΔRorc mice with Ire1a deleted in ILC3s. Intestinal infections were induced by Citrobacter rodentium and Clostridium difficile. ILC3s-derived cytokines including IL-22 is crucial for host defense in the acute phase of C. rodentium and C. difficile infection. Dextran sodium sulfate (DSS) was given in drinking water to induce acute colitis. We recruited patients with active Crohn’s disease (CD) and collected ileal biopsies during routine colonoscopy before starting ustekinumab, a non-selective anti-IL-23 antibody. Mucosal ILC3s were isolated for analysis of ILC3s by flow cytometry. Results In murine intestinal ILC3s, the activity of IRE1a-XBP1 pathway follows a robust 24h circadian rhythm which parallels that of clock genes and cytokines including IL-22. XBP1s is activated in ILC3s ex vivo by vasoactive intestinal peptide, which was previous shown to orchestrate the circadian expression of IL-22 by ILC3s. IRE1a-XBP1 in intestinal ILC3s is further activated in response to IL-23 and colitis in mice, as well as in inflamed IBD tissues compared to normal tissues from healthy individuals. We further showed that IRE1a-XBP1 activation in stimulated ILC3s requires mitochondrial reactive oxygen species (mtROS) (Fig 1). Using the Ire1aΔRorc mice, we demonstrated that IRE1a-XBP1 is critical for cytokine expression by ILC3s. Ire1aΔRorc mice are highly susceptible to acute C. rodentium and C. difficile infection as well as acute DSS colitis (similar vulnerabilities were found in Rag-/-Ire1aΔRorc mice compared to Rag-/-Ire1aflox/flox littermates). Ire1aΔRorc mice exhibit reduced IL-22 and IL-17A in ILC3s and impaired epithelial barrier function with diminished expression of mucins and antimicrobial peptides. The susceptibilities of Ire1aΔRorc and Rag-/-Ire1aΔRorc mice to colitis were rescued by administration of recombinant IL-22 (Fig 2). Moreover, the frequency of XBP1s+ ILC3s in ileal mucosa from CD patients before initiation of ustekinumab positively correlates with response to therapy. Conclusion We demonstrate that a non-canonical mtROS-IRE1a-XBP1 pathway augments cytokine production by intestinal ILC3s. We also identify XBP1+ ILC3s as a potential biomarker for predicting responsiveness to anti-IL-23 therapies in IBD.

PD-1 regulates ILC3-driven intestinal immunity and homeostasis

PD-1 signaling facilitates activation of lymphoid tissue inducer cells by restraining fatty acid oxidation

CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation

Bi-directional signaling between the intestinal epithelium and type-3 innate lymphoid cells regulates secretory dynamics and interleukin-22

The absence of interleukin 10 affects the morphology, differentiation, granule content and the production of cryptidin-4 in Paneth cells in mice

IEC-intrinsic IL-1R signaling holds dual roles in regulating intestinal homeostasis and inflammation

PD-L1 Restrains PD-1+Nrp1lo+Nrp1 Lo Treg Cells to Suppress Inflammation-Driven Colorectal Tumorigenesis

T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells

Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation

Title: PD-1 upregulation enhances the immunosuppression of group 2 innate 1 lymphoid cells by boosting IL-4 and IL-13 secretion in human non-small cell lung 2 cancer 3

Innate Lymphoid Cells Support Regulatory T Cells in the Intestine Through Interleukin-2.

Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation

PLZF Restricts Intestinal ILC3 Function in Gut Defense

Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93

ILC3 Function As a Double-Edged Sword in Inflammatory Bowel Diseases

IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

DOP89 Unfolded protein response controls group 3 innate lymphoid cells in IBD

ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut

Context-dependent role of group 3 innate lymphoid cells in mucosal protection

Regulatory Innate Lymphoid Cells Control Innate Intestinal Inflammation.